Dan Puckett - Feb 21, 2023 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role
Chief Financial Officer
Signature
/s/ Wade Estey, as attorney-in-fact for Dan Puckett
Stock symbol
SWAV
Transactions as of
Feb 21, 2023
Transactions value $
-$1,635,600
Form type
4
Date filed
2/23/2023, 07:08 PM
Previous filing
Feb 7, 2023
Next filing
Mar 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWAV Common Stock Options Exercise $18.7K +1.1K +2.67% $17.00* 42.3K Feb 21, 2023 Direct F1
transaction SWAV Common Stock Sale -$212K -1.1K -2.6% $192.84 41.2K Feb 21, 2023 Direct F1, F2
transaction SWAV Common Stock Tax liability -$742K -3.85K -9.35% $192.86 37.3K Feb 21, 2023 Direct F3
transaction SWAV Common Stock Sale -$700K -3.65K -9.79% $191.69 33.7K Feb 22, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SWAV Stock Option Options Exercise $0 -1.1K -48.25% $0.00 1.18K Feb 21, 2023 Common Stock 1.1K $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2022.
F2 All reported securities were sold at a price of $192.84.
F3 All reported securities were sold at a price of $192.86.
F4 1/48th of the shares subject to the option shall vest monthly from 03/06/2019.